Composition for diagnosis and treatment of alcoholic liver disease using changes in short-chain fatty acid-producing intestinal bacterial community

摘要

The present invention relates to a strain capable of acting as a biomarker for alcoholic fatty liver, and comprises a pharmaceutical composition for preventing or treating alcoholic fatty liver containing the strain as an effective component, for preventing or improving alcoholic fatty liver. It relates to a food composition or a probiotics composition for preventing or improving alcoholic fatty liver. [Selection diagram] FIG. 11